Project Grant F32GM165071
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded The Research Foundation for the State University of New York $645,070 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research investigating mitochondrial gene regulation in central nervous system development, with focus on how the transcription...
- The National Institute of General Medical Sciences awarded The Research Foundation For The State University of New York $434,892 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support structural and biosynthetic research on natural product enzymes. The award funds investigation of nonribosomal peptide synthetases (NRPSs) and NRPS-independent siderophore biosynthetic pathways, with focus on the conformational dynamics that NRPSs employ to...
- The National Institute of General Medical Sciences awarded The Research Foundation for the State University of New York $343,007 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to characterize glycosylation regulatory networks using single-cell multiomics and mathematical modeling. The project generates single-cell epigenomics, transcriptomics, and glycomics profiles during hematopoietic stem cell differentiation to identify key regulators and...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Research Foundation for the State University of New York a $2.2 million Project Grant on September 20, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to support fundamental research on transcription factor binding to chromatin. The research project, which runs through August 31, 2029, will systematically investigate the mechanistic rules governing how...
- The National Institute of General Medical Sciences, a sub-agency of the Department of Health and Human Services, awarded The Research Foundation For The State University Of New York $299,673 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate regulatory mechanisms of in vivo transcriptional dynamics. The recipient will conduct basic research to elucidate molecular mechanisms governing spatiotemporal regulation of transcriptional bursting...
- The National Institute of General Medical Sciences awarded The Research Foundation For The State University Of New York $896,502 on May 20, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing Project Grant) to conduct research on RNA polymerase I biogenesis and transcription regulation. The project investigates the molecular mechanisms governing assembly of the multi-subunit RNA polymerase I complex, the role of POL I subunits in driving...
- The National Institute of General Medical Sciences awarded The Research Foundation for the State University of New York $432,844 on July 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing) to fund development and application of dynamic, cell-instructive biomaterials that model mechanical regulation of macrophages in inflammation, tissue repair, fibrosis, and cancer. The award supports three integrated research innovations: curvature platforms...
- The National Institute of General Medical Sciences awarded The Research Foundation For The State University Of New York $562,820 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate liquid-liquid phase separation in the MLL1 core complex catalytic module and its role in histone H3 lysine 4 methylation underlying aggressive acute leukemias. The research defines structural features required for phase separation of the MWRAD2 complex...
- The National Institute of General Medical Sciences, National Institutes of Health, awarded The Research Foundation For The State University Of New York $191,000 on August 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to quantify RNA base-stacking energetics and their functional consequences under physiologically relevant conditions. The recipient will conduct systematic measurements of stacking energies across all 16 RNA base-stack combinations using a...
- The National Institutes of Health Office of the Director awarded The Research Foundation for the State University of New York $240,150 on February 1, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to modernize and refactor the SCRMSHAW computational software pipeline for discovering enhancers in genomic sequences. The award funds conversion of outdated Perl code to Python and C++ code to Rust, integration of SCRMSHAW data into the REDfly Database of Transcriptional Regulatory...
The National Institute of General Medical Sciences awarded The Research Foundation For The State University Of New York $153,560 on December 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the role of intrinsically disordered regions in regulating FOXG1-chromatin binding dynamics. The research investigates how intrinsically disordered regions outside the DNA-binding domain of FOXG1, a transcription factor regulating neurodevelopment, influence its function in chromatin binding, nuclear organization, and gene regulation. The work builds on preliminary findings that FOXG1 forms nanoscale clusters in cell nuclei that drive tight chromatin binding and that disease-associated variants with truncations in the central intrinsically disordered region lose this clustering and phase separation capability. The project will examine the conserved enrichment of aromatic amino acids within the central intrinsically disordered region and the role of biomolecular condensate formation via phase separation in FOXG1's association with DNA, with potential implications for understanding dozens of disease-associated mutations identified within these regions. Performance occurs at Buffalo, New York with a completion date of June 30, 2029. The Research Foundation For The State University Of New York, doing business as Sponsored Projects Services, serves as the fiscal agent administering the award on behalf of the State University of New York system. This is a Project Grant assistance type.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $76.8k | 6/1/26 | ||
| Not listed | $76.8k | 6/1/26 | ||
| Not listed | $0 | 6/1/26 |